Creatine Supplementation in Young Healthy Adults

Last updated: September 17, 2024
Sponsor: University of Regina
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

Creatine

Placebo

Clinical Study ID

NCT06604793
834
  • Ages 18-39
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

The purpose is to compare the effects of bolus ingestion (5 grams) vs. intermittent ingestion (2 x 2.5 grams) of creatine supplementation vs. placebo for 21 days on measures of body composition (lean tissue mass-indicator of muscle mass, total body water) and muscle performance (i.e., power, strength, endurance).

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • if you are 18-39 years of age

  • if you have not been performing resistance training for at least 4 weeks prior tothe start of the study.

Exclusion

Exclusion Criteria:

  • if you are pregnant or nursing

  • have taken creatine monohydrate within 30 days prior to the start of the study

  • if you have pre-existing allergies to the placebo (corn-starch maltodextrin)

Study Design

Total Participants: 42
Treatment Group(s): 2
Primary Treatment: Creatine
Phase:
Study Start date:
August 20, 2024
Estimated Completion Date:
January 31, 2025

Study Description

Creatine is a naturally occurring compound produced in the liver and brain. Creatine can also be found in food products such as red meat and seafood or through commercially available manufactured creatine products (i.e. creatine supplementation).

Evidence-based research shows that creatine supplementation improves measures of body composition and muscle performance. However, the optimal creatine supplementation protocol to achieve these benefits is unknown.

Connect with a study center

  • University of Regina

    Regina, Saskatchewan S4S 0A2
    Canada

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.